Kyto Technology and Life Science, Inc. (KBPH)
Kyto Technology and Life Science, Inc. operates in the Asset Management industry of the Financial Services sector, headquartered in Los Altos Hills, CA, US. The stock last traded at $1.00, down 45.65% on the session, giving a market capitalisation of $13.3M. On trailing twelve-month figures it carries a trailing P/E of 16.67, a net margin of 0.0%. Its beta of 0.02 implies it has historically moved less than the broad market.
Kyto Technology and Life Science, Inc. operates as a venture capital firm, primarily targeting nascent and early-stage enterprises. Its investment focus lies specifically within the technology and life science sectors. The firm's funding approach offers two main options: either secured convertible debt (which accrues interest and includes a conversion discount into preferred equity) or direct investment in preferred shares. Notably, Kyto Technology and Life Science does not take the lead role in financing rounds. Its investment capital is geographically distributed, with half allocated to ventures in the United States and the remainder supporting companies in Canada and Israel. Established in 1999, the company was formerly known as Kyto BioPharma, Inc. before rebranding in April 2018. It maintains its headquarters in Los Altos Hills, California, with a secondary office located in Scotts Valley, California.
Kyto Technology and Life Science, Inc. is most often compared with the following Financial Services names: